All Type of News
KPDS, “MOHW gave a preferential treatment on Novartis by imposing fines”
While most of the Novartis’ rebated products were imposed a fine, non-governmental organizations have made continuous criticisms about it.
The Korean Pharmacists for Democratic Society(KPDS), Healthy Right Network an...
67 pharmas with more than KRW 100 billion sales despite 18 companies with less than 20 million
Pharmaceutical companies which turned in an audit report to the Financial Supervisory Service last year reportedly raised sales by 9.5% on average, but decreased operating profits and net profits by 1.1% and 5.6%, res...
Daehan New Pharm expands business into facial beauty market via BNC Korea
Daehan New Pharm will expand its business into the facial beauty market by getting an exclusive sales license of a Korean filler manufacturer.
On the 27th, Daehan New Pharm announced it signed an exclusive sales agre...
Unlisted pharmas improved profitability by reducing SG&A expenses
It was observed that unlisted pharmaceutical companies, where most of them are small and medium companies, were able to raise profitability by reducing ‘selling, general and administrative(SG&A) expenses.’
According ...
Dong Wha Pharm signs exclusive sales agreement of Plavix to clinics in Korea with Sanofi-Aventis
Dong Wha Pharm(CEO Ji-Hoon Sohn) signed an exclusive distribution and sales agreement of Plavix(generic name: clopidogrel bisulfate), an anti-platelet drug, to Korean clinics with Sanofi.Aventis Korea(CEO Kyung-Eun Ba...
9 products suspended from health insurance benefits for provision of approx. KRW 2.6 billion rebates
Novartis’ 9 rebated drugs will be suspended from the health insurance benefits.
When it came to Novartis Korea’s issue about provision of rebates, the Ministry of Health and Welfare(MOHW) announced on the 27th that i...
“In regards to the support of the pharmaceutical and biotechnology fields, Korean drugs should be preferentially treated”
At a meeting with the National Health Insurance Service and Health Insurance Review & Assessment Service journalists on the 26th, Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) Chairman Hee-Mok W...
Main cause of nasal congestion is ‘allergic rhinitis’ for nasal spray users
GSK Consumer Healthcare(GSK CH, CEO Soo-Kyung Kim) announced the respondents chose allergic rhinitis as a cause of nasal congestion in a survey on people who recently used nasal spray.
In order to check awareness and...
Simplified procedure for Korean medicines to register in Argentina
Jointly dispatched by the Ministry of Health and Welfare(Minister Jin-Yup Jung, MOHW) and the Ministry of Foreign Affairs(Minister Byung-Sae Yoon, MOFA) to Argentina and Brazil for pharmaceutical and medical device co...
Term ‘natural new medicine’ will disappear
In order to avoid misconception to ‘new drug’ defined in the Pharmaceutical Affairs Law, the term ‘natural new medicine(literal translation)’ will no longer be used.
The Ministry of Food and Drug Safety(MFDS) pre-ann...
